Physician profile
Kyle W Stephens
NPI 1700084522
$6,836.68
in general payments reported to CMS, 2019-2025
15 companies · $1,330 in 2025
The $1,330 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,448 · 2020: $127 · 2021: $838 · 2022: $93.86 · 2023: $169 · 2024: $2,831 · 2025: $1,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,909 · Education: $1,500 · Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,908.78 |
| Education | $1,500.00 |
| Food and Beverage | $920.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,806.74 | 2019-2024 | |
| Medtronic, INC. | $1,890.44 | 2021-2025 | Ligasure, Signia, Progrip |
| Ethicon US, LLC | $876.83 | 2019-2022 | |
| Medical Device Business Services, INC. | $751.39 | 2019 | |
| Novo Nordisk INC | $167.34 | 2023-2025 | Wegovy, Saxenda |
| Boston Scientific Corporation | $71.32 | 2024 | Spyglass Discover |
| Tela Bio, INC. | $71.27 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ucb, INC. | $36.90 | 2025 | Rystiggo |
| Urovant Sciences INC | $27.88 | 2022 | |
| Incyte Corporation | $26.20 | 2024 | Monjuvi |
| Daiichi Sankyo INC. | $23.53 | 2023 | Injectafer |
| Kerecis Limited | $22.56 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Coloplast Corp | $21.87 | 2021 | |
| Axonics, INC. | $21.46 | 2023 | Axonics |
| Nestle Healthcare Nutrition INC. | $20.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.